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Stem cell based products are expected to emerge as a major paradigm in the development of novel therapies 
for the regeneration of functional tissues and organs [1]. Although somatic stem cells display both multipotency 
and self-renewal features, their natural ex vivo proliferative capability is rather limited. An alternative approach 
with great potential involves the use of pluripotent stem cells (PSCs), which can self-renew in vitro for prolonged 
periods while maintaining their intrinsic differentiation potential for all three embryonic germ lineages. In order to 
overcome the limited scalability of standard monolayer cultivations and to establish more defined cell culture 
conditions, bioreactor expansions in suspension using microcarriers, aggregated cell clumps and 
microencapsulation have been proposed [2]. Typically applied fed-batch and repeated batch cultures are limited 
in terms of maximum cell densities given the inability of hPSCs to perform oxidative phosphorylation [3], leading 
to excessive lactic acid accumulation and reduced proliferation after approximately one week of cultivation.  
In this study we adapted the technology of continuous stirred tank suspension culture for the production of large 
numbers of high quality human PSCs. Stem cells were cultivated as multicellular spheroids to guarantee 
survival in suspension, maintain their native microenvironment and prevent harmful harvesting procedures, as 
required for microcarrier cultures. The scale up was achieved in a 1L scale bioreactor equipped with an 
alternating tangential flow (ATF) system for cell retention to allow the renewal of spent medium and 
maintenance of key operating parameters (pH, oxygen pressure and temperature). The continuous exchange of 
medium prevented lactic acid accumulation as well as glucose limitation. The adaption of the perfusion rate to 
account for the increasing cell number led to very high cell densities, above 1∙107 cells/mL. By controlling the 
agitation rate, we were able to maintain a constant size of the aggregates, eliminating the need for passaging 
procedures and the use of Rho kinase inhibitors, thus bringing the system closer to a fully automated operation. 
The maintenance of hPSCs’ differentiation potential was confirmed by expression for pluripotency markers and 
differentiation into endo-, meso- and ectodermal lineages. Our work reports the achievement of high density 
human PSCs ex vivo expansion as suspended cell aggregates by controlled culture in perfusion mode. The 
fabrication of 10 billion pluripotent stem cells in a 1L fully automated bioreactor would be sufficient for the 
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